PBAC moves to reassure on biosimilars

white pills and tablets: GMiA
The PBAC has issued a statement intending to reassure the public about the safety of biosimilar copies of biologic drugs, in a bid to stamp out “misinformation” which could slow progress in biosimilars. The PBAC recently recommended allowing biologics to be substituted with biosimilar drugs by clinicians and pharmacists if the biosimilar is found to

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous UQ researchers in global hunt for new antibiotics
Next New sleep guidelines: educate the vulnerable